Tumor-stromal cytokine interactions in ovarian neoplasms.
Yale University School of Medicine, New Haven, CT 06520-8040, USA.
B M
BM
Kacinski
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D001201:Ascites / Q000503:physiopathology; D016207:Cytokines / Q000502:physiology*; D004848:Epithelium / Q000502:physiology / Q000503:physiopathology; D066246:ErbB Receptors / Q000502:physiology; D005260:Female; D016147:Genes, Tumor Suppressor; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D015850:Interleukin-6 / Q000502:physiology; D016173:Macrophage Colony-Stimulating Factor / Q000502:physiology; D009857:Oncogenes; D010051:Ovarian Neoplasms / Q000473:pathology / Q000503:physiopathology*; D010053:Ovary / Q000502:physiology; D010060:Ovulation; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000096:biosynthesis; D016186:Receptor, Macrophage Colony-Stimulating Factor / Q000502:physiology; D018123:Receptors, Interleukin / Q000502:physiology; D019947:Receptors, Interleukin-6; D017154:Stromal Cells / Q000502:physiology*
D015703:Antigens, CD; D016207:Cytokines; D066246:ErbB Receptors; D006133:Growth Substances; D015850:Interleukin-6; D016173:Macrophage Colony-Stimulating Factor; D018719:Erb-b2 Receptor Tyrosine Kinases; D016186:Receptor, Macrophage Colony-Stimulating Factor; D018123:Receptors, Interleukin; D019947:Receptors, Interleukin-6